Effects of TGF-β1 on endothelial factors

Archives of Physiology and Biochemistry

Volumn 116, Issue 1, 2010, Pages 50-55

  Cellier, Éric ^a   Midaoui, Adil El ^a   Robitaille, Genevive A ^a   Richard, Darren E ^a   Larivire, Richard ^a   Lebel, Marcel ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Cyclo oxygenase; Endothelin; Indomethacin; L NAME; Nitric oxide

Indexed keywords

CYTOKINE;

ANIMAL; ARTICLE; CELL LINE; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; MICE; SIGNAL TRANSDUCTION;

EID: 77949419479     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813451003610862     Document Type: Article

References (22)

1. Bradbury DA, Newton R, Zhu YM, Stocks J, Corbett L, Holland ED, Pang LH, Knox AJ. (2002). Effect of bradykinin, TGF-beta1, IL-1beta, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283:L717-25.
2. Brown MR, Vaughan J, Jimenez LL, Vale W, Baird A. (1991). Transforming growth factor-beta: role in mediating seruminduced endothelin production by vascular endothelial cells. Endocrinology 129:2355-2360
3. Dong, QG, Bernasconi, S, Lostaglio, S, De Calmanovici, RW, Martin-Padura, I, Breviario, F, Garlanda, C, Ramponi S, Mantovani A, Vecchi A. (1997). A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol 17:1599-1604
4. Dumont Y, D'Amours M, Lebel M, Larivière R. (2001). Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Nephrol Dial Transplant 16:746-754
5. Fakhouri F, Placier S, Ardaillou R, Dussaule JC, Chatziantoniou C. (2001). Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta. J Am Soc Nephrol 12:2701-2710
6. Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin, P, Tedgui A, Mallat Z, Groux H. (2003). Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102: 4052-4058
7. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. (1998). Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 40:352-363
8. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, Harrison DG. (1995). Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 15:1255-1261
9. Jackson BA, Goldstein RH, Roy R, Cozzani M, Taylor L, Polgar P. (1993). Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 197:1465-1474
10. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T. (2002). Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106:130-135
11. Lariviere R, D'Amours M, Lebel M, Kingma I, Grose JH, Caron L. (1997). Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass. Kidney Blood Press Res 20:372-380
12. Laviades C, Varo N, Diez J. (2000). Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension 36:517-522
13. Lavoie P, Robitaille G, Agharazii M, Ledbetter S, Lebel M, Lariviere R (2005). Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 23:1895-1903
14. Lebel M, Grose JH, Falardeau P. (1989). Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in man. Prostaglandins Leukot Essent Fatty Acids 35:41-49
15. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Matsumura Y. (2002). Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin Sci (Lond) 103, Suppl 48:68S-71S.
16. Phanish MK, Wahab NA, Colville-Nash P, Hendry BM, Dockrell ME. (2006). The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 393:601-607
17. Roman CD, Morrow J, Whitehead R, Beauchamp RD. (2002). Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-beta(1) in immortalized mouse colonocytes expressing oncogenic Ras. J Gastrointest Surg 6:304-309
18. Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HL, Beauchamp RD (1999). Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia 1:508-517
19. Umezono T, Toyoda M, Kato M, Miyauchi M, Kimura M, Maruyama M, Honma M, Yagame M, Suzuki D. (2006). Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy. J Nephrol 19:751-757
20. Vassalle C, Domenici C, Lubrano V, L'Abbate A. (2003). Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells. J Vasc Res 40:491-499
21. Vinals F, Pouyssegur J. (2001). Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol Cell Biol 21:7218-7230
22. Zou MH, Ullrich V. (1996). Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett 382:101-104